Amit Rakhit

Amit Rakhit, MD, MBA, is a highly experienced leader in the biopharmaceutical industry, currently serving as Chief Development and Medical Officer at BlueRock Therapeutics since June 2024. Prior to this role, Amit held notable positions including Chief Executive Officer at Flare Therapeutics and Sporos Bioventures, and Director at Asylia Therapeutics, Inc. and Stellanova Therapeutics. Amit’s extensive background also includes significant leadership roles at Ovid Therapeutics and Biogen, with a focus on medical and portfolio management. Educational credentials include an MD from Tufts University School of Medicine, two MBAs from Columbia and London Business Schools, and an MSCI from Vanderbilt University.